Written by the Core Power Peptides Research Team — biochemists and laboratory specialists compiling and verifying peptide research data. Learn about our quality standards →
Tesamorelin is one of the most studied growth hormone-releasing hormone (GHRH) analogues in modern peptide research. Known in the early literature by its developmental code TH9507, it is a synthetic peptide engineered to behave like the body’s own GHRH while resisting the rapid breakdown that limits the native hormone. This overview explains what tesamorelin is, how it is built, and why it has become a standard reference tool in growth hormone-axis research.
What Is Tesamorelin?
Tesamorelin is a fully synthetic 44-residue peptide amide that corresponds to the full-length human GHRH(1–44) sequence, with one key chemical modification. It is classified as a GHRH-receptor agonist, meaning it is studied for its ability to engage the same receptor that endogenous GHRH activates. It carries the CAS number 218949-48-5 and is supplied to laboratories as a lyophilised (freeze-dried) powder.
The TH9507 Origin
Before it was widely referred to as tesamorelin, the compound was developed and characterised under the code TH9507. Research programs at the time were focused on a well-known limitation of native GHRH: it is degraded within minutes by circulating enzymes, giving it a very short functional window. The goal behind TH9507 was to preserve GHRH’s receptor activity while engineering in far greater stability — a problem the molecule’s structure solves elegantly.
Molecular Structure and Formula
Tesamorelin is chemically designated N-(trans-3-hexenoyl)-[Tyr¹]hGRF(1–44)NH₂. Its molecular formula is C₂₂₁H₃₆₆N₇₂O₆₇S, with an average molecular weight of approximately 5,135.87 Da. The defining structural feature is the N-terminal trans-3-hexenoyl group attached to the terminal tyrosine residue. This single acylation is what separates tesamorelin from native GHRH and from other analogues, and it is the reason for the compound’s distinctive stability profile.
How Tesamorelin Works
In preclinical research, tesamorelin has been studied for its agonist activity at the growth hormone-releasing hormone receptor (GHRHR) on anterior-pituitary somatotrophs. When the peptide binds this receptor, research models have observed activation of the downstream cAMP/PKA signalling cascade, which in turn stimulates pulsatile, endogenous growth-hormone (GH) release. This “stimulate the body’s own production” mechanism is what makes tesamorelin valuable as a research probe: rather than introducing external GH, it engages the native signalling machinery, preserving the natural rhythm of hormone release that researchers study.
Why Stability Matters
The trans-3-hexenoic acid modification confers resistance to enzymatic cleavage by dipeptidyl peptidase-4 (DPP-4) — the same enzyme that rapidly breaks down native GHRH. This resistance is the practical advantage of tesamorelin in research: it remains intact long enough to support extended assay work and stability profiling, which are common focal points in method development involving the compound.
What Research Has Explored
Tesamorelin has an unusually developed body of published literature for a research peptide. Investigations have examined its effects on adipose tissue and metabolic parameters in controlled study designs — for example, a pooled analysis of phase 3 trials indexed on PubMed and a study on muscle and fat parameters via PMC. Within the GH-axis research field, it is frequently used as a reference GHRH agonist for probing endocrine feedback loops.
Tesamorelin vs Other GHRH Analogues
Tesamorelin is often compared with shorter GHRH fragments such as sermorelin. The two share the same receptor target but differ sharply in chain length and stability. For a full molecular and mechanistic breakdown, see our dedicated guide on Tesamorelin vs Sermorelin.
Storage and Handling in Research Settings
As a lyophilised peptide, tesamorelin is stored at −20°C for long-term preservation. Once reconstituted with bacteriostatic water for in-vitro work, it is held at 2–8°C, used within roughly 28 days, and protected from direct light and repeated freeze-thaw cycles. Proper handling preserves peptide integrity across a research protocol.
Where to Buy Tesamorelin for Research
Core Power Peptides supplies tesamorelin in multiple vial strengths for laboratory research: Tesamorelin 10mg, Tesamorelin 20mg, and Tesamorelin 2mg. Each is manufactured to a minimum 99%+ purity, verified by HPLC and mass spectrometry, and third-party tested with a certificate of analysis available on request.
This article is provided for informational and research context only. Tesamorelin is supplied strictly for in vitro and laboratory research use and is not intended for human consumption or therapeutic application. No medical or clinical claims are made.
